News Focus
News Focus
icon url

Jack2479

01/08/16 3:50 PM

#50108 RE: iclight #50106

Lol
icon url

flipper44

01/08/16 3:51 PM

#50109 RE: iclight #50106

Aye, mais ici, il a aussi dit:

"Our long-term aim is also to help the company get into a position where it can attract the consistent funding it will need to successfully complete a Phase III clinical study and beyond. If the company is going to move into a sustainable position to attract a broader range of investors that, in turn, will give it a runway to complete its clinical trials, it needs to put these allegations to rest once and for all.... -- Neil Woodford, a month ago



Then yesterday, after previously agreeing to NWBO's plans to hire Mr. Price, he said this:

Woodford Investment Management replied that they view the level of due diligence as adequate and the investment [Northwest Biotherapeutics] remains in the portfolio. -- January 7, 2016
icon url

Rkmatters

01/08/16 4:44 PM

#50114 RE: iclight #50106

I really hope you buy some shares if this goes into the pennies. You deserve a pay day for all the abuse you've taken on this iHub. :)
icon url

sentiment_stocks

01/08/16 8:14 PM

#50124 RE: iclight #50106

Yes, but IN DECEMBER Woodford also stated he intended to help NWBO make that destination a successful one in his blog dedicated entirely to Northwest Bio...

Our conviction in the technology and early clinical data, supported by globally leading oncology clinicians, is the principal factor in our investment. Our long-term aim is also to help the company get into a position where it can attract the consistent funding it will need to successfully complete a Phase III clinical study and beyond.

.

Whatever the issue is between Woodford and Linda, it's not centered around the outcome of the P3 trial.